Congestion in Acute Heart Failure Syndromes

An Essential Target of Evaluation and Treatment

Mihai Gheorghiade, Gerasimos Filippatos, Leonardo De Luca, John C Jr. Burnett

Research output: Contribution to journalArticle

243 Citations (Scopus)

Abstract

Patients with acute heart failure syndromes (AHFS) typically present with signs and symptoms of systemic and pulmonary congestion at admission. However, elevated left ventricular (LV) filling pressures (hemodynamic congestion) may be present days or weeks before systemic and pulmonary congestion develop, resulting in hospital admission. This "hemodynamic congestion," with or without clinical congestion, may have deleterious effects including subendocardial ischemia, alterations in LV geometry resulting in secondary mitral insufficiency, and impaired cardiac venous drainage from coronary veins resulting in diastolic dysfunction. It is possible that these hemodynamic abnormalities in addition to neurohormonal activation may contribute to LV remodeling and heart failure progression. Approximately 50% of patients admitted for AHFS are discharged with persistent symptoms and/or minimal or no weight loss in spite of the fact that the main reason for admission was clinical congestion. Accordingly, the assessment and management of pulmonary and systemic congestion in these patients require reevaluation.

Original languageEnglish (US)
JournalAmerican Journal of Medicine
Volume119
Issue number12 SUPPL.
DOIs
StatePublished - Dec 2006

Fingerprint

Heart Failure
Hemodynamics
Lung
Ventricular Remodeling
Mitral Valve Insufficiency
Ventricular Pressure
Signs and Symptoms
Weight Loss
Drainage
Coronary Vessels
Therapeutics
Ischemia

Keywords

  • Acute heart failure syndromes
  • Outcomes
  • Pulmonary congestion
  • Treatment

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Congestion in Acute Heart Failure Syndromes : An Essential Target of Evaluation and Treatment. / Gheorghiade, Mihai; Filippatos, Gerasimos; De Luca, Leonardo; Burnett, John C Jr.

In: American Journal of Medicine, Vol. 119, No. 12 SUPPL., 12.2006.

Research output: Contribution to journalArticle

Gheorghiade, Mihai ; Filippatos, Gerasimos ; De Luca, Leonardo ; Burnett, John C Jr. / Congestion in Acute Heart Failure Syndromes : An Essential Target of Evaluation and Treatment. In: American Journal of Medicine. 2006 ; Vol. 119, No. 12 SUPPL.
@article{ec6d09d2c2944711b0d0662922521fc8,
title = "Congestion in Acute Heart Failure Syndromes: An Essential Target of Evaluation and Treatment",
abstract = "Patients with acute heart failure syndromes (AHFS) typically present with signs and symptoms of systemic and pulmonary congestion at admission. However, elevated left ventricular (LV) filling pressures (hemodynamic congestion) may be present days or weeks before systemic and pulmonary congestion develop, resulting in hospital admission. This {"}hemodynamic congestion,{"} with or without clinical congestion, may have deleterious effects including subendocardial ischemia, alterations in LV geometry resulting in secondary mitral insufficiency, and impaired cardiac venous drainage from coronary veins resulting in diastolic dysfunction. It is possible that these hemodynamic abnormalities in addition to neurohormonal activation may contribute to LV remodeling and heart failure progression. Approximately 50{\%} of patients admitted for AHFS are discharged with persistent symptoms and/or minimal or no weight loss in spite of the fact that the main reason for admission was clinical congestion. Accordingly, the assessment and management of pulmonary and systemic congestion in these patients require reevaluation.",
keywords = "Acute heart failure syndromes, Outcomes, Pulmonary congestion, Treatment",
author = "Mihai Gheorghiade and Gerasimos Filippatos and {De Luca}, Leonardo and Burnett, {John C Jr.}",
year = "2006",
month = "12",
doi = "10.1016/j.amjmed.2006.09.011",
language = "English (US)",
volume = "119",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "12 SUPPL.",

}

TY - JOUR

T1 - Congestion in Acute Heart Failure Syndromes

T2 - An Essential Target of Evaluation and Treatment

AU - Gheorghiade, Mihai

AU - Filippatos, Gerasimos

AU - De Luca, Leonardo

AU - Burnett, John C Jr.

PY - 2006/12

Y1 - 2006/12

N2 - Patients with acute heart failure syndromes (AHFS) typically present with signs and symptoms of systemic and pulmonary congestion at admission. However, elevated left ventricular (LV) filling pressures (hemodynamic congestion) may be present days or weeks before systemic and pulmonary congestion develop, resulting in hospital admission. This "hemodynamic congestion," with or without clinical congestion, may have deleterious effects including subendocardial ischemia, alterations in LV geometry resulting in secondary mitral insufficiency, and impaired cardiac venous drainage from coronary veins resulting in diastolic dysfunction. It is possible that these hemodynamic abnormalities in addition to neurohormonal activation may contribute to LV remodeling and heart failure progression. Approximately 50% of patients admitted for AHFS are discharged with persistent symptoms and/or minimal or no weight loss in spite of the fact that the main reason for admission was clinical congestion. Accordingly, the assessment and management of pulmonary and systemic congestion in these patients require reevaluation.

AB - Patients with acute heart failure syndromes (AHFS) typically present with signs and symptoms of systemic and pulmonary congestion at admission. However, elevated left ventricular (LV) filling pressures (hemodynamic congestion) may be present days or weeks before systemic and pulmonary congestion develop, resulting in hospital admission. This "hemodynamic congestion," with or without clinical congestion, may have deleterious effects including subendocardial ischemia, alterations in LV geometry resulting in secondary mitral insufficiency, and impaired cardiac venous drainage from coronary veins resulting in diastolic dysfunction. It is possible that these hemodynamic abnormalities in addition to neurohormonal activation may contribute to LV remodeling and heart failure progression. Approximately 50% of patients admitted for AHFS are discharged with persistent symptoms and/or minimal or no weight loss in spite of the fact that the main reason for admission was clinical congestion. Accordingly, the assessment and management of pulmonary and systemic congestion in these patients require reevaluation.

KW - Acute heart failure syndromes

KW - Outcomes

KW - Pulmonary congestion

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=33751059230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751059230&partnerID=8YFLogxK

U2 - 10.1016/j.amjmed.2006.09.011

DO - 10.1016/j.amjmed.2006.09.011

M3 - Article

VL - 119

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 12 SUPPL.

ER -